ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

AVIR Atea Pharmaceuticals Inc

3.755
-0.045 (-1.18%)
Última actualización: 14:16:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Atea Pharmaceuticals Inc AVIR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.045 -1.18% 3.755 14:16:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.75 3.72 3.85 3.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/6/202415:04EDGAR2Form 144 - Report of proposed sale of securities
05/6/202406:00GLOBEAtea Pharmaceuticals Presents Positive Initial Phase 2 Data..
04/6/202415:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202406:00GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
22/5/202406:00GLOBEAtea Pharmaceuticals Presents New Data Showcasing Potential..
14/5/202415:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202415:16EDGAR2Form 8-K - Current report
14/5/202415:05GLOBEAtea Pharmaceuticals Reports First Quarter 2024 Financial..
07/5/202406:00GLOBEAtea Pharmaceuticals to Host First Quarter 2024 Financial..
29/4/202406:00GLOBEAtea Announces Presentation of Data Highlighting Favorable..
27/3/202406:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
28/2/202415:18EDGAR2Form 8-K - Current report
28/2/202415:05GLOBEAtea Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202406:00GLOBEAtea Pharmaceuticals to Host Fourth Quarter and Full Year..
02/2/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:15EDGAR2Form 144 - Report of proposed sale of securities
08/1/202415:05GLOBEAtea Pharmaceuticals Announces Positive Initial Data from..
03/1/202406:00GLOBEAtea Pharmaceuticals to Present at the 42nd Annual J.P...
13/11/202306:00GLOBEAtea Pharmaceuticals Presents Promising Bemnifosbuvir and..
08/11/202315:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:15EDGAR2Form 8-K - Current report
08/11/202315:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202306:00GLOBEAtea Pharmaceuticals Announces Participation at Upcoming..
02/11/202306:00GLOBEAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir..
01/11/202306:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2023 Financial..
06/9/202306:00GLOBEAtea Pharmaceuticals to Present at the Morgan Stanley 21st..
08/8/202315:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:21EDGAR2Form 8-K - Current report
08/8/202315:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202306:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2023 Financial..
15/6/202306:00GLOBEAtea Pharmaceuticals Announces First Patient Dosed in Phase..

Su Consulta Reciente

Delayed Upgrade Clock